Related Experiment Video
Updated: May 15, 2026

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with
Ramon J Whitson1, Marshall Scott Lucia, James R Lambert
1Department of Pathology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado 80045, USA.
Abstract:
Growth differentiation factor-15 (GDF-15) and the CCN family member, connective tissue growth factor (CCN2), are associated with cardiac disease, inflammation, and cancer. The precise role and signaling mechanism for these factors in normal and diseased tissues remains elusive. Here we demonstrate an interaction between GDF-15 and CCN2 using yeast two-hybrid assays and have mapped the domain of interaction to the von Willebrand factor type C domain of CCN2. Biochemical pull down assays using secreted GDF-15 and His-tagged CCN2 produced in PC-3 prostate cancer cells confirmed a direct interaction between these proteins. To investigate the functional consequences of this interaction, in vitro angiogenesis assays were performed. We demonstrate that GDF-15 blocks CCN2-mediated tube formation in human umbilical vein endothelial (HUVEC) cells. To examine the molecular mechanism whereby GDF-15 inhibits CCN2-mediated angiogenesis, activation of αV β3 integrins and focal adhesion kinase (FAK) was examined. CCN2-mediated FAK activation was inhibited by GDF-15 and was accompanied by a decrease in αV β3 integrin clustering in HUVEC cells. These results demonstrate, for the first time, a novel signaling pathway for GDF-15 through interaction with the matricellular signaling molecule CCN2. Furthermore, antagonism of CCN2 mediated angiogenesis by GDF-15 may provide insight into the functional role of GDF-15 in disease states.
Insights
Growth differentiation factor-15 (GDF-15) directly interacts with connective tissue growth factor (CCN2), inhibiting CCN2-driven angiogenesis. This discovery reveals a novel GDF-15 signaling pathway potentially impacting cardiac disease, inflammation, and cancer.
Area of Science:
- Molecular biology
- Cell biology
- Biochemistry
Background:
- Growth differentiation factor-15 (GDF-15) and connective tissue growth factor (CCN2) are implicated in cardiac disease, inflammation, and cancer.
- The precise roles and signaling mechanisms of GDF-15 and CCN2 in normal and diseased tissues are not fully understood.
Purpose of the Study:
- To investigate the interaction between GDF-15 and CCN2.
- To elucidate the functional consequences and molecular mechanisms of this interaction on angiogenesis.
Main Methods:
- Yeast two-hybrid assays to detect protein interactions.
- Biochemical pull-down assays to confirm direct binding.
- In vitro angiogenesis assays using human umbilical vein endothelial (HUVEC) cells.
- Examination of αV β3 integrin activation and focal adhesion kinase (FAK) signaling.
Main Results:
- A direct interaction between GDF-15 and CCN2 was confirmed, localized to the von Willebrand factor type C domain of CCN2.
- GDF-15 inhibited CCN2-mediated endothelial cell tube formation in vitro.
- GDF-15 blocked CCN2-induced focal adhesion kinase (FAK) activation.
- GDF-15 reduced αV β3 integrin clustering in HUVEC cells.
Conclusions:
- This study demonstrates a novel signaling pathway where GDF-15 interacts with the matricellular protein CCN2.
- GDF-15 antagonizes CCN2-mediated angiogenesis by inhibiting αV β3 integrin and FAK activation.
- This interaction provides new insights into the role of GDF-15 in disease pathogenesis.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
TGF - β Signaling Pathway
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Hematopoietic Stem Cells
Mitogens and the Cell Cycle

